☰

Ruifeng Xu, Ph.D. - Publications

Affiliations: 
2007 University of Wisconsin, Madison, Madison, WI 
Area:
Statistics
Tree Info Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Li ZZ, Bai L, Wang F, Zhang ZC, Wang F, Zeng ZL, Zeng JB, Zhang DS, Wang FH, Wang ZQ, Li YH, Shao JY, Xu RH. Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients. Medical Oncology (Northwood, London, England). 33: 71. PMID 27270901 DOI: 10.1007/s12032-016-0787-z  0.361
2016 Li ZZ, Wang F, Zhang ZC, Wang F, Zhao Q, Zhang DS, Wang FH, Wang ZQ, Luo HY, He MM, Wang DS, Jin Y, Ren C, Qiu MZ, Ren J, ... ... Xu RH, et al. Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response. Oncotarget. PMID 27050078 DOI: 10.18632/oncotarget.8541  0.365
2014 Qiu M, Zhou Y, Zhang X, Wang Z, Wang F, Shao J, Lu J, Jin Y, Wei X, Zhang D, Wang F, Li Y, Yang D, Xu R. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients. Bmc Cancer. 14: 823. PMID 25380654 DOI: 10.1186/1471-2407-14-823  0.335
2011 Li YH, Wang F, Shen L, Deng YM, Shao Q, Feng F, An X, Wang FH, Wang ZQ, Xu RH, Shao JY. EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 382-90. PMID 20884623 DOI: 10.1158/1078-0432.CCR-10-0208  0.364
Show low-probability matches.